Paras Biopharmaceuticals is a biopharmaceutical technology development company specializing in biologics and biosimilars. The company has developed therapeutic products for several indications, including osteoporosis, rheumatoid arthritis, metabolic disorders, and cancer. Paras Biopharmaceuticals has also developed proprietary technologies for the production and expression of peptides and proteins. The company also offers microbial biologics CDMO capabilities across a range of expression systems.